| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 12/30/2009 | WO2009155669A1 Method of treatment of vascular complications |
| 12/30/2009 | WO2009155662A1 A tumour suppressor protein, caspase-2 |
| 12/30/2009 | WO2009139811A3 Chemiluminescent methods and reagents for analyte detection |
| 12/30/2009 | WO2009137844A3 Pancreatic endocrine progenitor cells derived from pluripotent stem cells |
| 12/30/2009 | WO2009137713A3 Particle-based electrostatic sensing and detection |
| 12/30/2009 | WO2009137475A3 Compositions and methods for diagnosing late-onset alzheimer's disease |
| 12/30/2009 | WO2009137140A3 Methods of identifying an organism |
| 12/30/2009 | WO2009137136A9 In vivo gene sensors |
| 12/30/2009 | WO2009134612A3 Methods and compositions related to quantitative array based methylation analysis |
| 12/30/2009 | WO2009131948A8 High-throughput cell-based cftr assay |
| 12/30/2009 | WO2009131919A3 Polymerases for incorporating modified nucleotides |
| 12/30/2009 | WO2009131728A9 Compositions for use in identification of picornaviruses |
| 12/30/2009 | WO2009130320A3 Measurement of protein kinase activity in cerebrospinal fluid for diagnosis of neurological and psychiatric disorders |
| 12/30/2009 | WO2009129797A3 Stable lysis buffer mixture for extracting nucleic acids |
| 12/30/2009 | WO2009126730A9 Canine single chain fragment variable antibody libraries and uses thereof |
| 12/30/2009 | WO2009126718A3 Tumor-associated biomarkers from the dark proteom |
| 12/30/2009 | WO2009126517A3 Optimized probes and primers and methods of using same for the detection, quantification and grouping of hiv-1 |
| 12/30/2009 | WO2009126297A3 Induced heat shock proteins as biomarkers of risk of ischemia and/or paralysis |
| 12/30/2009 | WO2009125936A3 Analysis method and kit for diagnosis of polycystic ovary syndrome |
| 12/30/2009 | WO2009124150A3 Stabilized nucleic acid dark quencher-fluorophore probes |
| 12/30/2009 | WO2009123762A3 Method of screening single cells for the production of biologically active agents |
| 12/30/2009 | WO2009123667A3 Methods and compositions including diagnostic kits for the detection in samples of methicillin-resistant staphylococcus aureus |
| 12/30/2009 | WO2009120313A3 Identification of human t2r receptors that respond to bitter ligands in soy and related assays for identifying bitter taste modulators |
| 12/30/2009 | WO2009117661A3 Carrier neutralization assay |
| 12/30/2009 | WO2009117615A3 Novel divergent picornavirus:cosavirus |
| 12/30/2009 | WO2009117547A3 Markers and methods for assessing and treating severe or persistant asthma |
| 12/30/2009 | WO2009111476A3 Assay for systematic lupus erthematosus |
| 12/30/2009 | WO2009108170A3 Compositions and methods for determining immune status |
| 12/30/2009 | WO2009106308A3 System and method for improved processing of nucleic acids for production of sequencable libraries |
| 12/30/2009 | WO2009105592A3 Compositions and methods for detection of propionibacterium acnes nucleic acid |
| 12/30/2009 | WO2009105457A3 Slit2 cancer markers |
| 12/30/2009 | WO2009102748A3 Alternatively transcribed genes associated with schizophrenia |
| 12/30/2009 | WO2009102747A3 Alternatively transcribed genes associated with memory consolidation |
| 12/30/2009 | WO2009102369A3 Multiplex assay for respiratory viruses |
| 12/30/2009 | WO2009100342A3 Disease markers and uses thereof |
| 12/30/2009 | WO2009097262A3 Chitotriosidase and methods of use thereof |
| 12/30/2009 | WO2009094318A3 Molecular staging of stage ii and iii colon cancer and prognosis |
| 12/30/2009 | WO2009089102A3 Identification and characterization of pregnancy- associated genetic signatures and use thereof for diagnosis and treatment of breast cancer |
| 12/30/2009 | WO2009085468A3 A human non-antibody peptide or protein phage library |
| 12/30/2009 | WO2009085221A3 Detection of methicillin-resistant staphylococcus aureus |
| 12/30/2009 | WO2009076139A3 Thyroglobulin quantitation by mass spectrometry |
| 12/30/2009 | WO2009073751A3 Hair follicle pharmacodynamic assay for telomerase activity |
| 12/30/2009 | WO2009073628A3 Genetic polymorphisms associated with psoriasis, methods of detection and uses thereof |
| 12/30/2009 | WO2009072009A8 Method for determining the toxicity of a toxin or a toxoid |
| 12/30/2009 | WO2009062008A3 Methods and compositions for improved fertilization and embryonic survival |
| 12/30/2009 | WO2009061783A3 Dna microarray having hairpin probes tethered to nanostructured metal surface |
| 12/30/2009 | WO2009059018A9 Compositions and methods of enhancing immune responses to flagellated bacterium |
| 12/30/2009 | WO2009059014A3 Flow cell and system for detection of target in aqueous environment using arrayed imaging reflectometry |
| 12/30/2009 | WO2009055596A3 Methods of using genetic variants to diagnose and predict metabolic syndrome and associated traits |
| 12/30/2009 | WO2009048885A3 Assembly of large nucleic acids |
| 12/30/2009 | WO2009046457A3 Imaging of genetic material with magnetic resonance |
| 12/30/2009 | WO2009045545A3 Antidotes for agonistic aptamers |
| 12/30/2009 | WO2009039390A3 The development of glycobiology-based therapeutics for the treatment of brain tumors |
| 12/30/2009 | WO2009038594A3 Use of an in vitro hemodynamic endothelial/smooth muscle cell co-culture model to identify new therapeutic targets for vascular disease |
| 12/30/2009 | WO2009029321A3 Carboxylesterase-1 polymorphisms and methods of use therefor |
| 12/30/2009 | WO2009020677A3 Compositions and methods for inhibiting g protein signaling |
| 12/30/2009 | WO2009018431A3 Novel synthetic agonists of tlr9 |
| 12/30/2009 | WO2009018303A3 Methods for reverting methylation by targeting dnmt3a and dnmt3b |
| 12/30/2009 | WO2008154525A3 Predicting vaccine efficacy |
| 12/30/2009 | WO2008150937A3 Real-time pcr |
| 12/30/2009 | WO2008150473A3 Cytochrome p450 genes conferring herbicide resistance |
| 12/30/2009 | WO2008131215A3 Engineered phosphite dehydrogenase mutants |
| 12/30/2009 | WO2008129428A3 Methods, compositions and kits for detection and analysis of antibiotic-resistant bacteria |
| 12/30/2009 | WO2008122002A3 Organism identification panel |
| 12/30/2009 | WO2008119027A3 Genetic testing of telomere-associated genes in dyskeratosis congenita and related disorders |
| 12/30/2009 | WO2008118507A3 Recombinant human factor ix and use thereof |
| 12/30/2009 | WO2008109782A3 Diagnosis of inflammatory bowel disease in children |
| 12/30/2009 | WO2008088771A3 Adenylyl cyclases as novel targets for the treatment of infection by eukaryotic pathogens |
| 12/30/2009 | EP2138848A1 Method for the diagnosis and/or prognosis of cancer of the bladder |
| 12/30/2009 | EP2138843A1 Method for determining calibration information of electrochemical sensors |
| 12/30/2009 | EP2138590A1 Improved method for the prevention of carryover contamination in nucleic acid amplification technologies |
| 12/30/2009 | EP2138589A1 Molecular signature of liver tumor grade and use to evaluate prognosis and therapeutic regimen |
| 12/30/2009 | EP2138588A1 Melting curve measurement during amplification |
| 12/30/2009 | EP2138587A1 Amplification of nucleic acids using temperature zones |
| 12/30/2009 | EP2138582A2 DNA and specific peptides or proteins of bacteria of the species neisseria meningitidis, methods for obtaining same and their biological applications |
| 12/30/2009 | EP2138577A1 Probe for visualizing cell cycle |
| 12/30/2009 | EP2138511A1 HER3 as a determinant for the prognosis of melanoma |
| 12/30/2009 | EP2138510A1 Methods of generating antibodies against cytokines |
| 12/30/2009 | EP2138483A1 Oxidative color-developing compounds, salts thereof, process for production of the same, reagent compositions and test tools made by using the same |
| 12/30/2009 | EP2138232A1 Detection of tapped aliquots of amplified nucleic acids |
| 12/30/2009 | EP2138158A1 Hair growth-inhibiting agent |
| 12/30/2009 | EP2138033A1 Controlling starch synthesis |
| 12/30/2009 | EP2137539A1 Amiloride sensitive sodium channels associated with panic disorders |
| 12/30/2009 | EP2137529A1 Calibration and normalization method for biosensors |
| 12/30/2009 | EP2137528A2 Methods, computer-accessible medium, and systems for generating a genome wide haplotype sequence |
| 12/30/2009 | EP2137523A1 Plastic microfluidic separation and detection platforms |
| 12/30/2009 | EP2137522A1 Integrated nucleic acid analysis |
| 12/30/2009 | EP2137325A1 Biological markers predictive of rheumatoid arthritis response to b-cell antagonists |
| 12/30/2009 | EP2137324A2 Genetic variants on chr2 and chr16 as markers for use in breast cancer risk assessment, diagnosis, prognosis and treatment |
| 12/30/2009 | EP2137323A2 Ambient temperature stable chemical/biological reagents on membranes or filters |
| 12/30/2009 | EP2137322A1 Methods to identify modulators |
| 12/30/2009 | EP2137321A1 Methods for detecting a target nucleotide sequence in a sample utilising a nuclease-aptamer complex |
| 12/30/2009 | EP2136922A2 Methods of macromolecular analysis using nanochannel arrays |
| 12/30/2009 | EP2136843A1 Biomarkers of prostate cancer and uses thereof |
| 12/30/2009 | EP1929039B1 High throughput screening of mutagenized populations |
| 12/30/2009 | EP1628771B1 Thermal cycling apparatus for providing thermal uniformity |
| 12/30/2009 | EP1595120B1 Metal coated nanocrystalline silicon as an active surface enhanced raman spectroscopy (sers) substrate |
| 12/30/2009 | EP1523548B1 Polynucleotide sequences encoding alkaline a-galactosidases and methods of using same |
| 12/30/2009 | EP1470239B1 Psoriasin expression by breast epithelial cells |
| 12/30/2009 | EP1272663B1 Polymorphisms in the human cyp2b6 gene and their use in diagnostic and therapeutic applications |